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Robustness and replicability of psychopathology networks
Network approaches to psychopathology hold that mental
disorders arise from the interplay between symptoms in a net-
work structure1,2. In the past few years, statistical techniques
that estimate networks were developed and applied to many
disorders3. As empirical findings start to accumulate, the ques-
tion arising is which of these findings are robust and replica-
ble. Here we evaluate the state of psychopathological network
research based on three methodological criteria: model qual-
ity, precision, and replicability.
Model quality. One important quality of statistical modeling
techniques is their ability to recover the “true” model that gen-
erated the data, a necessary prerequisite for justifying infer-
ences based on network models. This is evaluated through: a)
mathematical analysis: prove that a technique will recover the
generating network model from data (e.g., by showing that it
converges to the true model as sample size increases); and b)
simulation studies: evaluate a technique’s performance under
various circumstances (e.g., for different network structures,
sample sizes, and parameter settings).
Current state-of-the-art network techniques (i.e., pairwise
Markov random fields4) have been vetted through mathemati-
cal proofs and simulation studies5,6: they efficiently recover
the “true” model underlying the data. In general, such tech-
niques minimize the false positive rate at the expense of statis-
tical power. As a result, these techniques are more likely to omit
“true” network connections, than to include spurious connec-
tions5,6. In sum, these techniques are vetted, conservative tools
for estimating psychopathology network structures.
Precision and robustness. When a researcher has estimated
a network from empirical data using vetted methodology, the
question is to what extent the parameter estimates are precise:
how robust are the results? For instance, if the relationship
between self-worth and suicidal thoughts seems stronger than
that between sleep difficulty and suicidal thoughts, it is neces-
sary to investigate if model parameters are estimated with suf-
ficient precision to justify this inference. If not, the result may
not replicate in other samples.
Precision of network parameter estimates can vary consid-
erably depending on factors such as sample size, network size,
and network structure. Therefore, these factors must be assess-
ed and reported on a case-by-case basis, by evaluating the sta-
tistical precision of parameter estimates (e.g., with confidence
intervals) and the robustness of the model as a whole (e.g.,
investigating network structures in subsamples).
Dedicated freeware methodology for doing this recently
became available4, which allows researchers to report confi-
dence intervals for estimated network parameters as an integral
part of their results. This practice was quickly embraced by the
majority of the network community, who now publish their
work including detailed robustness checks. Naturally, results of
such analyses should constrain the researcher’s conclusions
proportionately to their content: stronger claims (e.g., “insomnia
is the most central node in the depression network”) require
stronger evidence than weaker claims (e.g., “insomnia is con-
nected to the depression network”).
Replicability. When network analysis seems to warrant an
empirical conclusion (e.g., a particular symptom is highly cen-
tral, or one network is more densely connected than another),
the next question is whether the relevant phenomenon can be
replicated in other samples. Ideally, replication research differs
from the original study only in features that are deemed irrele-
vant to the phenomenon under investigation (e.g., by using a
different sample from the same population). However, as is
often the case in replication research, it is sometimes unclear
whether differences between a study and its purported replica-
tion are relevant or not. For instance, if a network is first esti-
mated on a community sample, and a replication is attempted
in a patient sample, it may be unrealistic to assume that the
same network holds in both populations. In such cases, studies
probe not only a finding’s replicability, but also its generaliz-
ability. Consequently, if inconsistent findings arise, this may
either be because the phenomenon is unstable or illusory (i.e.,
the finding is not replicable) or because of substantively mean-
ingful differences between studies (i.e., the finding is not gener-
alizable to the context of the new study). In contrast, if an em-
pirical phenomenon is observed consistently across studies, this
provides compound evidence for both its replicability and gene-
ralizability7.
Several recent empirical studies have evaluated the replica-
bility of networks. The general picture which emerges is that
network structures replicate and generalize well. For example,
networks of major depression and generalized anxiety disorder
symptoms are nearly identical in the US and Australia; post-
traumatic stress disorder (PTSD) networks are similar across
different populations and sources of trauma; and major depres-
sion networks are invariant across environmental and genetic
risk factors (e.g., age of onset)7,8.
Although network structures appear replicable and general-
izable, detailed inferences based on them may be more sus-
ceptible to variation across studies. For example, the centrality
of nodes seems to vary across PTSD networks, and a reported
difference in network density between remitted and persistent
major depression cases in adults was not fully replicated in an
adolescent sample8. Future research should critically interro-
gate such findings to determine if inconsistency between stud-
ies is best characterized as a failure to replicate or a failure to
generalize across contexts.
In conclusion, the model quality of network analysis tech-
niques is good, while precision and robustness can now ade-
quately be assessed with freely available methodological tools.
Burgeoning replication research suggests that the structure of
networks is typically consistent across studies, while stronger
inferences based on these structures (e.g., centrality) have
occasionally yielded mixed results.
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PERSPECTIVES
Network analysis is a promising approach that may lead to
significant improvements in research on and treatment of psy-
chopathology9, but researchers should be careful not to over-
state causal conclusions based on network analysis as long as
the causal interpretation of models has not been thoroughly
investigated. The assessment of network robustness and repli-
cability is an important step in this process and should be an
important research focus in the next few years.
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Accelerated biological aging in serious mental disorders
Individuals with serious mental disorders (SMDs) die at an
earlier average age, even after controlling for suicide1. They
are also at increased risk for developing somatic diseases that
are typically associated with advanced age, such as cardiovas-
cular diseases, metabolic syndrome, immune dysregulation
and dementia1.
The causes of this are likely multi-factorial, including ge-
netic predisposition, biological changes set in motion by early
life adversity, and lifestyle factors. Lifestyle factors, while obvi-
ously important, do not fully explain the increased mortality
and morbidity in these individuals, and consequently, “accel-
erated biological aging” is increasingly being seen as an intrin-
sic factor in SMDs, at least in some individuals2,3.
To the extent this hypothesis is true, the scope of patho-
physiology in these illnesses would broaden considerably, and
they might no longer be framed as only “mental disorders” or
even brain diseases, but rather as whole-body, multi-system
illnesses (or at least as illnesses with substantial somatic
comorbidity), of which the psychiatric presentation is just the
most readily observable pathology3. Understanding the medi-
ators of such potential acceleration of aging should expand
preventative and therapeutic opportunities to improve physi-
cal as well as mental health in affected individuals.
The notion of accelerated biological aging in SMDs is sup-
ported by reports of acceleration of certain biomarkers of age,
such as leukocyte telomere length2 and epigenetic age4. How-
ever, data on these biomarkers remain relatively sparse to this
point, and several questions arise: a) Do these markers mea-
sure aging per se, or just the presence of factors that them-
selves mediate aging? b) Are these markers causally related to
SMDs or just correlated with them? c) Is accelerated aging spe-
cific to particular psychiatric diagnoses or to certain physio-
logical perturbations that traverse diagnostic boundaries? d)
Do different aging biomarkers reflect the same or different
underlying aging processes? Here I briefly review recent data
pertinent to these questions.
Leukocyte telomere length and epigenetic age both signifi-
cantly track chronological age, with correlation coefficients of
20.38 to 20.51 (for the former) and 0.96 (for the latter). Both
of these markers significantly predict disease and mortality,
strengthening the view that they are measurable markers of
the aging process and of rates of aging. However, leukocyte
telomere length and epigenetic age are independent predictors
of chronological age and mortality risk5. Therefore, while they
both measure processes that evolve with aging or are associ-
ated with aging, the specific processes are different, and their
underlying mediators likely differ.
Telomere shortening can occur in response to inflamma-
tion, oxidative stress, stress hormones and other factors2,3. As
such, it may signal the cumulative presence of a toxic cellular
environment, rather than directly informing on the aging pro-
cess itself. Indeed, leukocyte telomere length is often found to
be inversely correlated with circulating inflammatory and oxi-
dative stress factors2,3. Another major determinant of telomere
shortening is a cell’s mitotic history, since telomeres fail to
fully replicate after each cell division, unless acted upon by the
intracellular enzyme telomerase.
When cells reach a critically short telomere length, they
may undergo replicative senescence, apoptosis, genomic in-
stability or oncogenic transformation2. This can be especially
problematic in tissues whose mitotic capacity is necessary for
cellular replacement, such as hematopoietic stem cells and –
of particular relevance to psychiatry – neuronal stem cells in
the dentate gyrus of the hippocampus. Of great concern (and
also of great preventative opportunity), early life stress, even in
utero, has been associated with shortened leukocyte telomere
length in newborns and in adults.
Telomeres in SMDs may progressively shorten with illness
chronicity and/or severity, but, interestingly, even never-de-
pressed girls at high genetic risk for developing depression
already have short telomeres compared to girls at low genetic
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